Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04034927
Brief Title: Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer

First Submitted : July 25, 2019
First Submitted that Met QC Criteria : July 25, 2019
First Posted : July 29, 2019

Last Update Submitted that Met QC Criteria : December 17, 2020
Last Update Posted : December 19, 2020